Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Combination of viral and bacterial antigens
Patent
1982-04-22
1984-06-12
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Combination of viral and bacterial antigens
424252, 424255, 424263, 424266, 424280, 424319, A61K 3168, A61K 31365, A61K 31525, A61K 3151
Patent
active
044541252
ABSTRACT:
Dry, stable, self-lubricating formulations for use as pharmaceuticals or vitamin/mineral supplements, which do not require the inclusion of fillers, lubricants, binders and other conventional excipients, and which exhibit excellent free flowability and compressibility characteristics, are produced by incorporating crystalline ascorbic acid or physiologically acceptable ascorbate salts therein.
REFERENCES:
patent: 2477491 (1949-07-01), Miller
patent: 2816854 (1957-12-01), Gross
patent: 3160564 (1964-12-01), Hanus
patent: 3175948 (1965-03-01), Koff et al.
patent: 3740432 (1973-06-01), Magid
LandOfFree
Dry powder formulations having improved flow and compressibility does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dry powder formulations having improved flow and compressibility, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dry powder formulations having improved flow and compressibility will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-121077